Unknown PHASE4 INTERVENTIONAL 2-arm NCT04863742

Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL (ENHANCE)

Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing Femtosecond Laser-Assisted Cataract Surgery With Premium Intraocular Lens - The ENHANCE Study

Sponsor: Ocular Therapeutix, Inc.

Conditions Dry Eye Syndromes

Interventions Dextenza 0.4Mg Ophthalmic Insert Prednisolone Acetate

Updated 4 times since 2021 Last updated: Apr 26, 2021 Started: Apr 26, 2021 Primary completion: Jul 31, 2021 Completion: Sep 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Dry Eye Syndromes, this trial is ongoing. The trial is conducted by Ocular Therapeutix, Inc. and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
May 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Recruiting PHASE4

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ocular Therapeutix, Inc.
Sight Medical Doctors PLLC

Data source: Sight Medical Doctors PLLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brentwood, United States